Skip to main content
Novavax, Inc. (NVAX)
NASDAQ: NVAX · Real-Time Price · USD
7.92
-0.15 (-1.86%)
At close: Apr 28, 2026, 4:00 PM EDT
7.97
+0.05 (0.63%)
After-hours: Apr 28, 2026, 7:59 PM EDT

Novavax Market Cap

Novavax has a market cap or net worth of $1.29 billion as of April 28, 2026. Its market cap has increased by 36.92% in one year.

Market Cap
1.29B
Enterprise Value
833.42M
1-Year Change
36.92%
Ranking
#2391
Category
Small-Cap
Stock Price
$7.92

Market Cap Chart

Since December 1, 1998, Novavax's market cap has increased from $25.70M to $1.29B, an increase of 4,921.22%. That is a compound annual growth rate of 15.35%.

History

DateMarket Cap% Change
Apr 28, 20261.29B18.18%
Dec 31, 20251.09B-15.21%
Dec 31, 20241.29B125.87%
Dec 29, 2023570.20M-29.34%
Dec 30, 2022807.00M-92.54%
Dec 31, 202110.82B52.38%
Dec 31, 20207.10B6,609.55%
Dec 31, 2019105.80M-84.98%
Dec 31, 2018704.40M81.13%
Dec 29, 2017388.90M13.78%
Dec 30, 2016341.80M-84.90%
Dec 31, 20152.26B60.10%
Dec 31, 20141.41B32.47%
Dec 31, 20131.07B281.83%
Dec 31, 2012279.60M92.96%
Dec 30, 2011144.90M-46.33%
Dec 31, 2010270.00M8.56%
Dec 31, 2009248.70M90.28%
Dec 31, 2008130.70M-36.71%
Dec 31, 2007206.50M-18.35%
Dec 29, 2006252.90M33.74%
Dec 30, 2005189.10M46.70%
Dec 31, 2004128.90M-28.82%
Dec 31, 2003181.10M182.53%
Dec 31, 200264.10M-80.46%
View and export this data all the way back to 1998. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Maze Therapeutics 1.43B
Iovance Biotherapeutics 1.42B
Viridian Therapeutics 1.42B
Wave Life Sciences 1.38B
Olema Pharmaceuticals 1.35B
Corvus Pharmaceuticals 1.35B
ArriVent BioPharma 1.34B
MapLight Therapeutics 1.31B
Market Cap Rankings